Floris van Delft

Company: Synaffix

Job title: Head, R&D

Seminars:

Synaffix/Lonza End-to-End Offering to Best-in-Class Targeted-Therapies Based on GlycoConnect® & HydraSpace® Technologies 10:00 am

• Exploring how GlycoConnect® and HydraSpace® technologies enable ADCs with best-in-class therapeutic potential • Sharing clinical development insights on the rapidly advancing pipeline of GlycoConnect® ADCs by partners • Discussing technology expansion towards bispecific (bYlok®) and dual warhead ADCs with compelling in vivo data • Presenting unprecedented mRNA exon skipping and dystrophin restoration in preclinical…Read more

day: Conference Day Two pt 1